SEC Form 4 · accession 0000874015-17-000015

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Patrick R. O'Neil

Officer — SVP, Legal & General Counsel

Period of report

Jan 15, 2017

Accepted (ET)

Jan 18, 2017 · 6:37 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000874015

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jan 15, 2017	M	312	$0.00	A	10,262	D
Common Stock^F2	Jan 17, 2017	S	122	$46.293	D	10,140	D
Common Stock^F1	Jan 15, 2017	M	653	$0.00	A	10,793	D
Common Stock^F2	Jan 17, 2017	S	256	$46.29	D	10,537	D
Common Stock^F3	Jan 15, 2017	M	1,875	$0.00	A	12,412	D
Common Stock^F4	Jan 17, 2017	S	733	$46.29	D	11,679	D
Common Stock^F5	Jan 15, 2017	M	1,311	$0.00	A	12,990	D
Common Stock^F6	Jan 17, 2017	S	512	$46.291	D	12,478	D
Common Stock^F7	Jan 15, 2017	M	1,594	$0.00	A	14,072	D
Common Stock^F8	Jan 17, 2017	S	623	$46.29	D	13,449	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F9,F10	—	Jan 15, 2017	A	7,537	A	—	—	Common Stock	7,537	7,537	D
Restricted Stock Units^F2,F9,F11	—	Jan 15, 2017	M	312	D	—	—	Common Stock	312	0	D
Restricted Stock Units^F2,F9,F11	—	Jan 15, 2017	M	653	D	—	—	Common Stock	653	0	D
Restricted Stock Units^F4,F9,F11	—	Jan 15, 2017	M	1,875	D	—	—	Common Stock	1,875	1,875	D
Restricted Stock Units^F6,F9,F11	—	Jan 15, 2017	M	1,311	D	—	—	Common Stock	1,311	2,620	D
Restricted Stock Units^F8,F9,F11	—	Jan 15, 2017	M	1,594	D	—	—	Common Stock	1,594	4,779	D

Explanation of responses

F1Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2013.
F10Grant 1/15/2017 to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
F11Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
F2The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2013.
F3Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2014.
F4The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2014.
F5Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2015.
F6The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2015.
F7Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2016.
F8The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2016.
F9Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.